|
Re: My one-minute commercial for Apabetalone
|
2
|
Resverlogix Corp.
|
Sep 10, 2019 10:14PM
|
|
Re: Curiosity questions
|
2
|
Resverlogix Corp.
|
Mar 01, 2020 09:01PM
|
|
Re: Zenith Capital Corp. Announces Annual and Special Meeting Webcast Details
|
2
|
Zenith Epigenetics
|
Dec 07, 2016 09:06PM
|
|
Re: Resverlogix Announces Presentation at 9th Annual Biotech Showcase Conference in San Francisco, CA
|
2
|
Resverlogix Corp.
|
Jan 06, 2017 02:18PM
|
|
New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
2
|
Zenith Epigenetics
|
Jun 13, 2016 04:27PM
|
|
Re: Third Eye Loan
|
2
|
Resverlogix Corp.
|
Dec 28, 2018 12:13PM
|
|
Re: Nice volume surge at the end....
|
2
|
Resverlogix Corp.
|
Jun 28, 2017 12:17PM
|
|
Re: What are the biggest hints that BETonMACE will be a huge success,..
|
2
|
Resverlogix Corp.
|
Oct 02, 2018 02:17PM
|
|
BioPub Bioasis Webcast
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 30, 2019 10:34PM
|
|
Bioasis to Present at Upcoming Industry Conferences
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 07, 2020 10:13AM
|
|
Re: Q1 events list updated
|
2
|
Resverlogix Corp.
|
Jan 11, 2017 11:11AM
|
|
Re: Dosing to end of trial
|
2
|
Resverlogix Corp.
|
Jan 21, 2019 11:10PM
|
|
Bio Investor Forum October 20-21st; BETonMACE announcement?
|
2
|
Resverlogix Corp.
|
Oct 13, 2015 03:26PM
|
|
Re: Breakthrough Therapy Designation Application
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 11:39AM
|
|
Re: ZZXY
|
2
|
Zenith Epigenetics
|
May 13, 2018 08:41PM
|
|
RVX-208 Moderated Poster Presentation at IAS 2015 May 26, 2015
|
2
|
Resverlogix Corp.
|
May 18, 2015 01:49PM
|
|
Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 10:08AM
|
|
ZEN-3694 mCRPC trial no longer recruiting
|
2
|
Zenith Epigenetics
|
Apr 30, 2019 05:14PM
|
|
Re: Back to $1.40.....
|
2
|
Resverlogix Corp.
|
Mar 08, 2016 02:21PM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
2
|
Resverlogix Corp.
|
Nov 29, 2018 11:49AM
|
